These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15536342)

  • 1. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry.
    Curtin K; Slattery ML; Holubkov R; Edwards S; Holden JA; Samowitz WS
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):380-6. PubMed ID: 15536342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
    Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
    Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
    Xu L; Chen YT; Huvos AG; Zlotolow IM; Rettig WJ; Old LJ; Garin-Chesa P
    Diagn Mol Pathol; 1994 Jun; 3(2):83-92. PubMed ID: 8061893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications.
    Lleonart ME; García-Foncillas J; Sánchez-Prieto R; Martín P; Moreno A; Salas C; Ramón y Cajal S
    Cancer; 1998 Sep; 83(5):889-95. PubMed ID: 9731891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
    Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
    Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
    Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
    Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing.
    Chakravarty G; Redkar A; Mittra I
    Br J Cancer; 1996 Oct; 74(8):1181-7. PubMed ID: 8883402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
    Samowitz WS; Holden JA; Curtin K; Edwards SL; Walker AR; Lin HA; Robertson MA; Nichols MF; Gruenthal KM; Lynch BJ; Leppert MF; Slattery ML
    Am J Pathol; 2001 Apr; 158(4):1517-24. PubMed ID: 11290569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
    Ryu JW; Lee MC; Jang WC
    J Korean Med Sci; 2000 Feb; 15(1):73-7. PubMed ID: 10719813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.
    Karim S; Ali A
    World J Gastroenterol; 2009 Mar; 15(11):1381-7. PubMed ID: 19294769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors.
    Voskuil DW; Kampman E; van Kraats AA; Balder HF; van Muijen GN; Goldbohm RA; van't Veer P
    Int J Cancer; 1999 May; 81(5):675-81. PubMed ID: 10328215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations and expression in ovarian cancers: correlation with overall survival.
    Wen WH; Reles A; Runnebaum IB; Sullivan-Halley J; Bernstein L; Jones LA; Felix JC; Kreienberg R; el-Naggar A; Press MF
    Int J Gynecol Pathol; 1999 Jan; 18(1):29-41. PubMed ID: 9891239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p53 mutations in colon cancer at the population level.
    Samowitz WS; Curtin K; Ma KN; Edwards S; Schaffer D; Leppert MF; Slattery ML
    Int J Cancer; 2002 Jun; 99(4):597-602. PubMed ID: 11992552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of p53 tumor-suppressor gene and microsatellites in preneoplastic and neoplastic lesions of the colon and esophagus.
    Copelli SB; Mazzeo C; Gimenez A; Casco C; Meiss R; Rubio H; Speroni A; Vanzulli S
    Oncol Rep; 2001; 8(4):923-9. PubMed ID: 11410811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R; Deng G; Selph C; Carroll P; Presti J
    Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.